Literature DB >> 21558495

Frailty modeling of the bimodal age-incidence of Hodgkin lymphoma in the Nordic countries.

Tom Grotmol1, Freddie Bray, Harald Holte, Marion Haugen, Lauren Kunz, Steinar Tretli, Odd O Aalen, Tron A Moger.   

Abstract

BACKGROUND: The bimodality of the age-incidence curve of Hodgkin lymphoma (HL) has been ascribed to the existence of subgroups with distinct etiologies. Frailty models can be usefully applied to age-incidence curves of cancer to aid the understanding of biological phenomena in these instances. The models imply that for a given disease, a minority of individuals are at high risk, compared with the low-risk majority.
METHODS: Frailty modeling is applied to interpret HL incidence on the basis of population-based cancer registry data from the five Nordic countries for the period 1993 to 2007. There were a total of 8,045 incident cases and 362,843,875 person-years at risk in the study period.
RESULTS: A bimodal frailty analysis provides a reasonable fit to the age-incidence curves, employing 2 prototype models, which differ by having the sex covariate included in the frailty component (model 1) or in the baseline Weibull hazard (model 2). Model 2 seemed to fit better with our current understanding of HL than model 1 for the male-to-female ratio, number of rate-limiting steps in the carcinogenic process, and proportion of susceptibles; whereas model 1 performed better related to the heterogeneity in HL among elderly males.
CONCLUSION: The present analysis shows that HL age-incidence data are consistent with a bimodal frailty model, indicating that heterogeneity in cancer susceptibility may give rise to bimodality at the population level, although the individual risk remains simple and monotonically increasing by age. IMPACT: Frailty modeling adds to the existing body of knowledge on the heterogeneity in risk of acquiring HL. ©2011 AACR

Entities:  

Mesh:

Year:  2011        PMID: 21558495     DOI: 10.1158/1055-9965.EPI-10-1014

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  9 in total

1.  Prostate-specific antigen testing for prostate cancer: Depleting a limited pool of susceptible individuals?

Authors:  Morten Valberg; Tom Grotmol; Steinar Tretli; Marit B Veierød; Tron A Moger; Susan S Devesa; Odd O Aalen
Journal:  Eur J Epidemiol       Date:  2016-07-18       Impact factor: 8.082

2.  Frailty modeling of age-incidence curves of osteosarcoma and Ewing sarcoma among individuals younger than 40 years.

Authors:  Morten Valberg; Tom Grotmol; Steinar Tretli; Marit B Veierød; Susan S Devesa; Odd O Aalen
Journal:  Stat Med       Date:  2012-06-29       Impact factor: 2.373

3.  Evaluating the number of stages in development of squamous cell and adenocarcinomas across cancer sites using human population-based cancer modeling.

Authors:  Julia Kravchenko; Igor Akushevich; Amy P Abernethy; H Kim Lyerly
Journal:  PLoS One       Date:  2012-05-22       Impact factor: 3.240

4.  Invariant Characteristics of Carcinogenesis.

Authors:  Simon Sherman; Nirosha Rathnayake; Tengiz Mdzinarishvili
Journal:  PLoS One       Date:  2015-10-14       Impact factor: 3.240

5.  HIV and Hodgkin Lymphoma Survival: A Prospective Study in Botswana.

Authors:  Kaelo Moahi; Tlotlo Ralefala; Isaac Nkele; Scott Triedman; Aliyah Sohani; Zola Musimar; Jason Efstathiou; Philipe Armand; Shahin Lockman; Scott Dryden-Peterson
Journal:  JCO Glob Oncol       Date:  2022-01

6.  Modeling age-specific incidence of colon cancer via niche competition.

Authors:  Steffen Lange; Richard Mogwitz; Denis Hünniger; Anja Voß-Böhme
Journal:  PLoS Comput Biol       Date:  2022-08-19       Impact factor: 4.779

7.  Basic equations and computing procedures for frailty modeling of carcinogenesis: application to pancreatic cancer data.

Authors:  Tengiz Mdzinarishvili; Simon Sherman
Journal:  Cancer Inform       Date:  2013-02-18

8.  Heuristic modeling of carcinogenesis for the population with dichotomous susceptibility to cancer: a pancreatic cancer example.

Authors:  Tengiz Mdzinarishvili; Simon Sherman
Journal:  PLoS One       Date:  2014-06-16       Impact factor: 3.240

9.  Incidence patterns and review of Hodgkin lymphoma in the Republic of Armenia.

Authors:  Jemma Arakelyan; Alisa Movsisyan; Lilit Sargsyan; Armine Chopikyan; Diana Andreasyan; Arevik Torosyan; Ruzanna Papyan; Hovhannes Vardevanyan; Samvel Bardakhchyan; Artashes Tadevosyan; Gevorg Tamamyan; Armen Tananyan; Samvel Danielyan; Dickran Kazandjian
Journal:  Ecancermedicalscience       Date:  2021-11-18
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.